Diagnostics and Genomics: South Asia’s Growth Story

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I bring over two decades of leadership experience in clinical diagnostics and life sciences, with a strong focus on market development, commercial transformation, and strategic partnerships across India and South Asia.

My expertise spans Clinical Dx , Molecular diagnostics, genomics, and clinical workflows – Allergy , Autoimmunity, TDM ,Transplant Dx , where I have led high-growth portfolios, built large cross-functional teams, and driven double-digit growth while improving EBITDA.

I’ve worked extensively on scaling advanced technologies (NGS, PCR, clinical automation) in emerging markets—balancing innovation adoption with affordability and access, which is critical in this region.

Q2. How are evolving healthcare priorities across South Asia shaping demand for advanced diagnostics and genetic testing?

Healthcare priorities in South Asia are shifting from acute care to continuum-based care, driven by:

• Rising non-communicable diseases (NCDs)
• Increased health awareness and screening programs
• Government push for universal healthcare access
• Sample to report – POCT devices 

This is accelerating demand for:

• Early diagnostics and screening (oncology, Reproductive health , infectious diseases)
• Genetic testing and precision medicine, especially in oncology and rare diseases
• Decentralized testing models (tier …